Company intelligence / Profile preview

Zar Group

Ownership: Private
Development stage: Commercial

Overview

Zar Group—through its subsidiary Zarpharma—produces high-quality pharmaceutical raw materials and auxiliary substances such as medicinal starches, glucose, fructose syrups, maltodextrin, perigel starches. The company operates a GMP-compliant facility with clean rooms and has obtained necessary regulatory licenses. It supplies tens of tons of these ingredients daily to the pharma industry and has begun exporting to Europe. During the COVID-19 pandemic it played a key role in supplying essential alcohol production inputs for healthcare needs.

Modalities: Small moleculeBiologic
Industry: Chemicals & Materials

Partnerships

National Institute of Nutrition and ResearchFood and Drug Administration Research CenterStandard Research Institute

Beyond the preview

Go deeper on Zar Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zar Group.

Explore the full profile